96 related articles for article (PubMed ID: 30489433)
21. Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control study.
Tanaka LF; Schriefer D; Radde K; Schauberger G; Klug SJ
PLoS One; 2021; 16(7):e0253801. PubMed ID: 34260601
[TBL] [Abstract][Full Text] [Related]
22. Temporal Patterns of Cervical Cancer Screening Among Danish Women 55 Years and Older Diagnosed With Cervical Cancer.
Hammer A; Hee L; Blaakær J; Gravitt P
J Low Genit Tract Dis; 2018 Jan; 22(1):1-7. PubMed ID: 29271849
[TBL] [Abstract][Full Text] [Related]
23. Association between cervical screening and prevention of invasive cervical cancer in Ontario: a population-based case-control study.
Vicus D; Sutradhar R; Lu Y; Kupets R; Paszat L;
Int J Gynecol Cancer; 2015 Jan; 25(1):106-11. PubMed ID: 25377725
[TBL] [Abstract][Full Text] [Related]
24. Elderly women above screening age diagnosed with cervical cancer have a worse prognosis.
Darlin L; Borgfeldt C; Widén E; Kannisto P
Anticancer Res; 2014 Sep; 34(9):5147-51. PubMed ID: 25202106
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer incidence in ontario women: differing sociodemographic gradients by morphologic type (adenocarcinoma versus squamous cell).
Prummel MV; Young SW; Candido E; Nishri D; Elit L; Marrett LD
Int J Gynecol Cancer; 2014 Sep; 24(7):1341-6. PubMed ID: 25054446
[TBL] [Abstract][Full Text] [Related]
26. Review of the screening history of Alberta women with invasive cervical cancer.
Stuart GC; McGregor SE; Duggan MA; Nation JG
CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
[TBL] [Abstract][Full Text] [Related]
27. About invasive cervical cancer: a French population based study between 1998 and 2010.
Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
[TBL] [Abstract][Full Text] [Related]
28. Efficiency of cytological screening for detection of cervical squamous carcinoma. A study in the county of Uppsala 1991-1994.
Jansson A; Gustafsson M; Wilander E
Ups J Med Sci; 1998; 103(2):147-54. PubMed ID: 9923069
[TBL] [Abstract][Full Text] [Related]
29. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
Castanon A; Landy R; Sasieni PD
Int J Cancer; 2016 Sep; 139(5):1040-5. PubMed ID: 27096255
[TBL] [Abstract][Full Text] [Related]
30. Invasive cervical cancer incidence and mortality among canadian women aged 15 to 29 and the impact of screening.
Popadiuk C; Stankiewicz A; Dickinson J; Pogany L; Miller AB; Onysko J
J Obstet Gynaecol Can; 2012 Dec; 34(12):1167-1176. PubMed ID: 23231799
[TBL] [Abstract][Full Text] [Related]
31. A review of cervical cancer patients presenting in Harare and Parirenyatwa Hospitals in 1998.
Chirenje ZM; Rusakaniko S; Akino V; Mlingo M
Cent Afr J Med; 2000 Oct; 46(10):264-7. PubMed ID: 11682933
[TBL] [Abstract][Full Text] [Related]
32. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer in South Australia: trends in incidence, mortality and case survival.
Bonett A; Davy M; Roder D
Aust N Z J Obstet Gynaecol; 1989 Aug; 29(3 Pt 1):193-6. PubMed ID: 2604645
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
[TBL] [Abstract][Full Text] [Related]
35. Screening for cervical carcinoma in HIV-infected women: Analysis of main risk factors for cervical cytologic abnormalities.
Sansone M; Saccone G; Migliucci A; Saviano R; Capone A; Maruotti GM; Bruzzese D; Martinelli P
J Obstet Gynaecol Res; 2017 Feb; 43(2):352-357. PubMed ID: 28026078
[TBL] [Abstract][Full Text] [Related]
36. Age-specific effectiveness of the Finnish cervical cancer screening programme.
Lönnberg S; Anttila A; Luostarinen T; Nieminen P
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1354-61. PubMed ID: 22665576
[TBL] [Abstract][Full Text] [Related]
37. Survival of Older Women With Cervical Cancer Based on Screening History.
Clark M; Jembere N; Wang L; Kupets R
J Low Genit Tract Dis; 2021 Jan; 25(1):9-14. PubMed ID: 33347044
[TBL] [Abstract][Full Text] [Related]
38. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
39. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
Costa MJ; Kenny MB; Naib ZM
Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
